An interventional study of Low pressure group and Normal pressure group in Intracranial Pressure Increase, Abdominal Pain and Head Pain, sponsored by Diskapi Yildirim Beyazit Education and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by Diskapi Yildirim Beyazit Education and Research Hospital · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Intracranial Hypertension with a site in Turkey — 4 open to participants now, 4 under way, none of them phase 3. Intracranial Hypertension · Turkey.
Among the 26 studies in Intracranial Hypertension with a site in Turkey, this one is the 2nd largest by enrollment of the 18 interventional ones that give a count, is one of 2 that started in 2025, is one of 18 with no phase, and was the 24th registered.
166 studies on the registry are indexed under Intracranial Hypertension; 37 are open to participants now.
Browse Intracranial Hypertension studies →4 of the 26 studies in Intracranial Hypertension with a site in Turkey are open now. Recruiting first, the newest first:
Kartal Kosuyolu High Speciality Training and Research Hospital · Sites in Turkey
Ages 18–75
Başakşehir Çam & Sakura City Hospital · Sites in Turkey
Ages 18–65 · Healthy volunteers
Haseki Training and Research Hospital · Sites in Turkey
Ages 18–80
Kocaeli University · Sites in Turkey
Ages 18+ · Women only · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 23 Intracranial Hypertension studies recruiting now, 11 (48%) set no upper age limit and 5 (22%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.
This study: 18 Years to 65 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 99 is above the median of 50 across 81 interventional studies indexed under Intracranial Hypertension.
Median enrollment 60 across the 18 interventional studies, 80 across the 8 observational. Of the 21 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 26 has an industry lead sponsor. The 10 most frequent:
Diskapi Yildirim Beyazit Education and Research Hospital is the lead sponsor of 71 studies on the registry; 12 are open to participants now.
Diskapi Yildirim Beyazit Education and Research Hospital has 1 study filed under Intracranial Hypertension — fewer than ten, so there is no comparison to draw.
1 of the studies in Intracranial Hypertension with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07420738Kartal Kosuyolu High Speciality Training and Research HospitalEffects of Extracorporeal Circulation Techniques on Cerebral Perfusion in CABG Surgery | 2027-05-01 |
Add it to your calendar (.ics) → With an account.
Among the 26 studies in Intracranial Hypertension with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to investigate the effects of low and normal intraperitoneal pressures on intraoperative optic nerve sheath diameter in laparoscopic gyneco-oncologic surgeries.
Gynecological surgeries are minimally invasive procedures. The establishment of pneumoperitoneum, special patient positioning, and surgical stimulation can induce a stress response in patients. Carbon dioxide (CO₂) pneumoperitoneum and the Trendelenburg position lead to increases in intra-abdominal, intrathoracic, and airway pressures, which in turn may directly or indirectly cause elevations in intracranial and intraocular pressures.
During the perioperative period, the optic nerve sheath diameter (ONSD), measured ultrasonographically, is used as a reliable method to estimate intracranial pressure (ICP). Monitoring ICP under anesthesia may help prevent neurological complications such as neurological deterioration and optic neuropathy. Furthermore, studies have demonstrated ICP changes in robotic and laparoscopic gynecologic surgeries through ultrasonographic measurement of ONSD.
Traditionally, laparoscopic abdominal surgeries are performed using intraperitoneal pressures ranging between 10 and 18 mmHg. Lower intra-abdominal pressures have been associated with reduced postoperative pain, improved pulmonary parameters, and a decreased risk of gas embolism. However, the data on these outcomes remain limited.
In this study, investigators aimed to investigate the effect of pressures above and below 12 mmHg on the optic nerve sheath diameter-and consequently on intracranial pressure-in patients undergoing laparoscopic gynecologic surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In laparoscopic gyneco-oncological surgeries, low pressure group received below 12 mmHg intraperitoneal pressure.
Other: Low pressure group
In laparoscopic gyneco-oncological surgeries, normal pressure group received 12 and abowe 12 mmHg intraperitoneal pressure.
Other: Normal pressure group
In laparoscopic gyneco-oncological surgeries, low pressure group will receive below 12 mmHg intraperitoneal pressure.
In laparoscopic gyneco-oncological surgeries, normal pressure group will receive 12 and abowe 12 mmHg intraperitoneal pressure.
Measurement of optic nerve sheath diameter (ONSD)
ONSD will be measured in the supine position by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.
Time frame: 30 minutes after introducing pneumoperitoneum and position change
Measurement of optic nerve sheath diameter (ONSD)
ONSD will be measured by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.
Time frame: The baseline ONSD measurement will be performed 5 minutes after endotracheal intubation
Measurement of optic nerve sheath diameter (ONSD)
ONSD will be measured in the supine position by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.
Time frame: 5 minutes after introducing pneumoperitoneum and position change
Measurement of optic nerve sheath diameter (ONSD)
ONSD will be measured by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.
Time frame: 60 minutes after introducing pneumoperitoneum and position change
Measurement of optic nerve sheath diameter (ONSD)
ONSD will be measured by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.
Time frame: 90 minutes after introducing pneumoperitoneum and position change
Measurement of optic nerve sheath diameter (ONSD)
ONSD will be measured in the supine position by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.
Time frame: The ONSD measurement will be performed 5 minutes after the pneumoperitoneum is released and the Trendelenburg position is corrected.
numerical rating scale (NRS) at rest
Recording the patient's pain at rest on the Numerical Rating Scale (NRS) by asking the patient
Time frame: popstoperative 1. hour
numerical rating scale (NRS) at rest
Recording the patient's pain at rest on the Numerical Rating Scale (NRS) by asking the patient
Time frame: popstoperative 8. hours
postoperative nosia and vomiting (PONV)
Recording the presence or absence of nausea and vomiting in the patient within the first 24 hours postoperatively
Time frame: popstoperative 1. hour
postoperative nosia and vomiting (PONV)
Recording the presence or absence of nausea and vomiting in the patient within the first 24 hours postoperatively
Time frame: popstoperative 8. hours
headache
The presence or absence of headache will be assessed and documented.
Time frame: popstoperative 8. hours
Plan to share: Undecided
Ran from Aug 2025 to primary completion in Feb 2026, 5 months.
Of 37 non-industry interventional studies with no phase under Intracranial Hypertension, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 39. This study's 5 months is below that.
Counting every sponsor, half of 38 studies reached it within 18 months; a quarter within 6 and three quarters within 39.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Oct 2025 → Feb 2026 and completion Oct 2025 → Mar 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Diskapi Yildirim Beyazit Education and Research Hospital